New Pathway Identified: Splenic Tr1 Cells Drive Transplant Tolerance via Areg–EGFR Signaling
January 8, 2026
Brand Name :
Integrilin
Synonyms :
Class :
Antiplatelet agents; Glycoprotein receptor antagonists
Dosage forms & Strengths:
Adult:
IV solution:
2 mg/ml
0.75 mg/ml
180
mcg/kg
Solution
Intravenous (IV)
1 - 2
minutes
Later, 2 mcg/kg/min intravenously for 72 hours
Safety and efficacy are not seen in pediatrics
The efficacy of eptifibatide may be increased by aspirin rectal due to pharmacodynamic synergism
may enhance the effects by pharmacodynamic synergism when combined with eptifibatide
1-10%:
Bleeding (8%)
Hypotension (7%)
Thrombocytopenia (2.3%)
Injection site reaction
<1%:
Hypersensitivity
Pulmonary hemorrhage
Intracranial hemorrhage
GI hemorrhage
Thrombocytopenia
Pregnancy consideration:
Category C.
Breastfeeding warnings:
No data is available regarding the presence of the drug in breast milk.
Pregnancy category:
Patient information leaflet
Generic Name: eptifibatide
Pronounced: epti-fiba-tide
Why do we use eptifibatide?
Eptifibatide belongs to the category of antiplatelet agents. It is used to treat acute coronary syndrome and percutaneous coronary intervention.